Age: 18 - 65
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of North Carolina, Chapel Hill
No Placebo Group
Trial Summary
What is the purpose of this trial?The goal of this study is to learn the extent to which client-therapist brain activity may synchronize during a psychosocial intervention for depression symptoms.
The study will compare behavioral activation, a client-centered type of cognitive-behavioral therapy, to psychoeducation which delivers information on strategies to recover from depression symptoms.
Participants will answer questions about their mental and physical health, attend one psychosocial intervention session receiving either Behavioral Activation or Psychoeducation with simultaneous brain activity measurement and complete follow up surveys two weeks and one month following the intervention.
Eligibility Criteria
This trial is for individuals experiencing stress, depression, or anxiety. Participants should be willing to discuss their mental and physical health, attend a therapy session where their brain activity will be measured, and complete follow-up surveys.Inclusion Criteria
I am between 18 and 30 years old.
I understand the study and can give informed consent.
Participant Groups
The study aims to compare the effects of Behavioral Activation (a type of cognitive-behavioral therapy) with Psychoeducation on people with depression symptoms by measuring how well client-therapist brain activities sync during sessions.
2Treatment groups
Experimental Treatment
Active Control
Group I: Behavioral ActivationExperimental Treatment1 Intervention
Behavioral Activation (BA) is a psychotherapy modality that can be used to treat depression. The 60 minute session of BA is designed to actively engage with the client in creating personalized goals and ways in which maladaptive coping mechanisms maintaining depression can be addressed and replaced with increased exposure to positive reinforcement.
Group II: PsychoeducationActive Control1 Intervention
Psychoeducation will be used in this study as a control condition. The 60 minute session will be structured to provide general educational information on depression and evidence-based strategies to reduce symptoms. The information will be presented in generic format and will not be tailored to be client-specific.
Behavioral Activation is already approved in United States, China, European Union for the following indications:
🇺🇸 Approved in United States as Behavioral Activation Therapy for:
- Depression
- Anxiety in older adults undergoing cardiac procedures
🇨🇳 Approved in China as Behavioral Activation Therapy for:
- Loneliness in older adults
- Depression
🇪🇺 Approved in European Union as Behavioral Activation Therapy for:
- Depression
- Anxiety
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
Carolina Center for NeurostimulationChapel Hill, NC
Loading ...
Who is running the clinical trial?
University of North Carolina, Chapel HillLead Sponsor
Foundation of Hope, North CarolinaCollaborator